Document is current
Any future updates will be listed below
-
Authors
Tack, Celine
Van den Houte, Karen
Besard, Linde
Capiau, Luc
Ceulemans, Steven
Gernay, Olivier
Maes, Sophie
Peetermans, Christian
Raat, Willem
Stubbe, Jeroen
Van Boxstael, Rudy
Vandeput, Olivia
Van Steenbergen, Sophie
Gehesquière, Bjorn
Raes, Jeroen
Tack, Jan
Carbone, Florencia
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek
- License Information
-
More Information
Article History
Received: 2 March 2025
Accepted: 19 November 2025
First Online: 23 December 2025
Declarations
:
: This study involves human participants and was approved by the Ethical Committee Research UZ/KU Leuven (S59482). Participants gave informed consent to participate in the study before taking part. All study procedures were performed in accordance to the 1975 Declaration of Helsinki.
: Not applicable.
: JT has given Scientific advice to AlfaWassermann, Allergan, Christian Hansen, Danone, Grünenthal, Ironwood, Janssen, Kiowa Kirin, Menarini, Mylan, Neutec, Novartis, Noventure, Nutricia, Shionogi, Shire, Takeda, Theravance, Tramedico, Truvion, Tsumura, Zealand and Zeria pharmaceuticals, has received research support from Shire, Sofar and Tsumura, and has served on the Speaker bureau for Abbott, Allergan, AstraZeneca, Janssen, Kyowa Kirin, Menarini, Mylan, Novartis, Shire, Takeda, Truvion and Zeria. Funding was provided by a Methusalem grant from Leuven University to JTThis study was supported by a research grant from the Belgian Health Care Knowledge Centre (KCE).Questionnaires in this trial were provided by the Rome Foundation research Institute. This study was supported by a research grant from the Belgian Health Care Knowledge Centre (KCE). Questionnaires in this trial were provided by the Rome Foundation research Institute.
